World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
85
Citations
28956
World Ranking
1308
National Ranking
50

Medicine

D-Index
85
Citations
28956
World Ranking
14525
National Ranking
558

Marina Noris publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Marina Noris sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 307 publications — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Marina Noris D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Marina Noris sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 85 D-Index — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Marina Noris is affiliated with the Mario Negri Institute for Pharmacological Research in Italy. Their research predominantly focuses on medicine, with significant contributions in immunology and microbiology. Within these domains, their work emphasizes immunology, nephrology, and hematology, alongside studies related to infectious diseases and genetics.

The scientist has concentrated on several main topics in their research, including:

  • Complement system in diseases
  • Renal diseases and glomerulopathies
  • Blood groups and transfusion
  • SARS-CoV-2 and COVID-19 research
  • Platelet disorders and treatments
  • COVID-19 clinical research studies
  • Blood coagulation and thrombosis mechanisms

Marina Noris has published extensively in several prominent academic venues. The most frequent outlets include:

  • Kidney International
  • Frontiers in Immunology
  • Kidney International Reports
  • Zenodo (CERN European Organization for Nuclear Research)
  • Journal of the American Society of Nephrology

Among their recent papers are:

  • The case of complement activation in COVID-19 multiorgan impact, 2020, Kidney International
  • The state of complement in COVID-19, 2021, Nature Reviews. Immunology
  • Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group, 2020, Blood
  • Genetic testing in the diagnosis of chronic kidney disease: recommendations for clinical practice, 2021, Nephrology Dialysis Transplantation
  • The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference, 2024, Kidney International

The scientist collaborates frequently with several other researchers, including:

  • Giuseppe Remuzzi
  • Ariela Benigni
  • Roberta Donadelli
  • Elena Bresin
  • Rossella Piras

Best Publications

  • Atypical Hemolytic–Uremic Syndrome

    Marina Noris;Giuseppe Remuzzi

  • Relative Role of Genetic Complement Abnormalities in Sporadic and Familial aHUS and Their Impact on Clinical Phenotype

    Marina Noris;Jessica Caprioli;Elena Bresin;Chiara Mossali

  • Overview of complement activation and regulation.

    Marina Noris;Giuseppe Remuzzi

  • Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome.

    Jessica Caprioli;Marina Noris;Simona Brioschi;Gaia Pianetti

  • Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

    Timothy H.J. Goodship;H. Terence Cook;Fadi Fakhouri;Fernando C. Fervenza

  • Hemolytic Uremic Syndrome

    Marina Noris;Giuseppe Remuzzi

  • Nitric Oxide Synthesis by Cultured Endothelial Cells Is Modulated by Flow Conditions

    Marina Noris;Marina Morigi;Roberta Donadelli;Sistiana Aiello

  • Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura

    Piero Ruggenenti;Marina Noris;Giuseppe Remuzzi

  • Thrombomodulin mutations in atypical hemolytic-uremic syndrome.

    Mieke Delvaeye;Marina Noris;Astrid De Vriese;Charles T. Esmon

  • Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells.

    Federica Casiraghi;Nadia Azzollini;Paola Cassis;Barbara Imberti

  • STEC-HUS, atypical HUS and TTP are all diseases of complement activation

    Marina Noris;Federica Mescia;Giuseppe Remuzzi

  • The state of complement in COVID-19

    Unknown

  • Mechanisms of Disease: pre-eclampsia

    Marina Noris;Norberto Perico;Giuseppe Remuzzi

  • Combined Complement Gene Mutations in Atypical Hemolytic Uremic Syndrome Influence Clinical Phenotype

    Elena Bresin;Erica Rurali;Jessica Caprioli;Pilar Sanchez-Corral

  • Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome

    Tamara Manuelian;Jens Hellwage;Seppo Meri;Jessica Caprioli

  • C3 glomerulopathy — understanding a rare complement-driven renal disease

    Richard J.H. Smith;Gerald B. Appel;Anna M. Blom;H. Terence Cook

  • Familial haemolytic uraemic syndrome and an MCP mutation.

    Marina Noris;Simona Brioschi;Jessica Caprioli;Marta Todeschini

  • Dynamics of complement activation in aHUS and how to monitor eculizumab therapy

    Marina Noris;Miriam Galbusera;Sara Gastoldi;Paolo Macor

  • Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease

    Jessica Caprioli;Federica Castelletti;Sara Bucchioni;Paola Bettinaglio

  • Autologous Mesenchymal Stromal Cells and Kidney Transplantation: A Pilot Study of Safety and Clinical Feasibility

    Norberto Perico;Federica Casiraghi;Martino Introna;Eliana Gotti

  • The Molecular Basis of Familial Hemolytic Uremic Syndrome: Mutation Analysis of Factor H Gene Reveals a Hot Spot in Short Consensus Repeat 20

    Jessica Caprioli;Paola Bettinaglio;Peter F. Zipfel;Barbara Amadei

  • The case of complement activation in COVID-19 multiorgan impact.

    Marina Noris;Ariela Benigni;Giuseppe Remuzzi

  • Natural versus adaptive regulatory T cells.

    Linda Cassis;Sistiana Aiello;Marina Noris

  • ATYPICAL HEMOLYTIC UREMIC SYNDROME AND C3 GLOMERULOPATHY: CONCLUSIONS FROM A «KIDNEY DISEASE: IMPROVING GLOBAL OUTCOMES» (KDIGO) CONTROVERSIES CONFERENCE

    Timothy H.J. Goodship;H. Terence Cook;Fadi Fakhouri;Fernando C. Fervenza

Frequent Co-Authors

Giuseppe Remuzzi
Giuseppe Remuzzi Mario Negri Institute for Pharmacological Research
Ariela Benigni
Ariela Benigni Mario Negri Institute for Pharmacological Research
Norberto Perico
Norberto Perico Mario Negri Institute for Pharmacological Research
Timothy H.J. Goodship
Timothy H.J. Goodship Newcastle University
Piero Ruggenenti
Piero Ruggenenti Mario Negri Institute for Pharmacological Research
Santiago Rodríguez de Córdoba
Santiago Rodríguez de Córdoba Spanish National Research Council
Carla Zoja
Carla Zoja Mario Negri Institute for Pharmacological Research
Peter F. Zipfel
Peter F. Zipfel Friedrich Schiller University Jena

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees can open diverse career opportunities. Advanced nursing degrees, such as a Doctor of Nursing Practice (DNP), offer specialized knowledge and increased earning potential. Understanding how much do dnps make helps prospective students gauge the financial benefits of this career path across different states.

Nurses aiming to deepen their expertise might consider shifting roles, like transitioning from a Family Nurse Practitioner (FNP) to an Acute Care Nurse Practitioner (ACNP). Insights on fnp to acnp transitions provide guidance on educational and certification requirements for these specialized careers.

For those looking to accelerate their path, an accelerated fnp program online offers a streamlined route to becoming a Family Nurse Practitioner, addressing the growing demand for primary care providers.

Additionally, many online nursing programs cater to beginners without nursing backgrounds. Exploring online nursing programs for non nurses can help aspiring healthcare professionals start their journey in nursing and immunology.

Best Scientists Citing Marina Noris

Trending Scientists

Recently Published Articles